|
Sealy, Robert; Zhan, Xiaoyan; Lockey, Timothy D et al. (2009) SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development? Curr HIV Res 7:497-503
|
|
Lockey, Timothy D; Zhan, Xiaoyan; Surman, Sherri et al. (2008) Epstein-Barr virus vaccine development: a lytic and latent protein cocktail. Front Biosci 13:5916-27
|
|
Bonsignori, Mattia; D'Costa, Sybil; Surman, Sherri et al. (2007) A combination of 5-fluorouracil and membrane-bound antibody inhibits B-cell lymphoma growth in a mouse model system. Leuk Lymphoma 48:406-9
|
|
Brown, Scott A; Lockey, Timothy D; Slaughter, Clive et al. (2005) T cell epitope ""hotspots"" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry. AIDS Res Hum Retroviruses 21:165-70
|
|
Slobod, Karen S; Coleclough, Chris; Bonsignori, Mattia et al. (2005) HIV vaccine rationale, design and testing. Curr HIV Res 3:107-12
|
|
Zhan, Xiaoyan; Martin, Louis N; Slobod, Karen S et al. (2005) Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV. Vaccine 23:5306-20
|
|
D'Costa, Sybil S; Hurwitz, Julia L (2003) Phytohemagglutinin inhibits lymphoid tumor growth in vitro and in vivo. Leuk Lymphoma 44:1785-91
|
|
Zhan, Xiaoyan; Brown, Brita; Slobod, Karen S et al. (2003) Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine. Transplantation 76:739-40
|
|
D'Costa, Sybil; Hurwitz, Julia L (2003) Customized mitogen or antibody treatments enhance the sensitivity of lymphoid tumors to 5-fluorouracil in vitro and in vivo. Leuk Lymphoma 44:841-7
|
|
D'Costa, Sybil; Slobod, Karen S; Hurwitz, Julia L (2003) Do the immunosuppressive drugs used as treatment for graft-versus-host disease directly inhibit lymphoid tumor cell growth? Leuk Lymphoma 44:139-42
|
Showing the most recent 10 out of 40 publications
